News for hackers. Stuff that matters.
Re:A cancer trial’s unexpected result: Remission in every pa... by gjreda on Sunday June 05, 2022 @05:15PM (#31634923)
Imatinib (Gleevac) revolutionized treatment for patients with chronic myeloid leukemia (CML). Prior to the drug’s discovery, CML patients generally had seven years to live (possibly less depending on how advanced the cancer was). Now their lifespan mirrors the general population.

I’d highly recommend the book The Philadelphia Chromosome if you’re interested in learning more.

Re:A cancer trial’s unexpected result: Remission in every pa... by macdaknife on Sunday June 05, 2022 @08:45PM (#31636259)
I am currently taking a similar drug for Myelofibrosis on a clinical trial holed up after a stem cell transplant here at MD Anderson Cancer Center. It's called Itacitinib, and is supposed to prevent GVHD. It's by the same company that makes Jakafi (brand name). These are expensive drugs for sure, and my DR is running the clinical trial. Just wanted to chime in from the inside. ;p
Re:A cancer trial’s unexpected result: Remission in every pa... by moneywoes on Sunday June 05, 2022 @10:54PM (#31636903)
Best of luck for your treatment